You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Pharma & Healthcare

Global Immunology Drug Industry Research Report, Growth Trends and Competitive Analysis 2021-2027

The immune system is an assembly of structures and processes inside the body to protect against possibly damaging foreign bodies and diseases. It identifies various threats like bacteria, viruses, and parasites and distinguishes them from body's healthy tissues. When the immune system weakness and lose the capability to detect and destroy the abnormal cells or body attacks and damages its tissues lead to diseases like cancer and autoimmune diseases. Immunotherapy is a process which includes the treatment by inducing, enhancing or suppressing an immune system to fight against the diseases.
The global Immunology Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
In terms of production side, this report researches the Immunology Drug production capacity, value, ex-factory price, growth rate, market share by manufacturers, regions (or countries) and by Type.
In terms of consumption side, this report focuses on the consumption of Immunology Drug by regions (countries) and by Application.
The global Immunology Drug market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Immunology Drug market. These figures have been provided in terms of both revenue and volume for the period 2016-2027. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise Immunology Drug markets such as North America, Europe, China and Japan, etc. Key regions covered in the report are U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E
For the period 2016-2027, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Immunology Drug market. For the period 2016-2021, it provides sales (consumption) analysis and forecast of different regional markets by each application as well as type segment in terms of volume.
Manufacturers
The report includes comprehensive company profiling of leading and emerging companies competing in the global Immunology Drug market. It provides a detailed list of players operating at a global level. The players have been listed according to the type of products they offer in the global Immunology Drug market and other factors. As part of the company profiling, the analysts authoring the report has provided the market entry year of each player considered for the research study. The report also offers extensive price, volume sales, and revenue analysis by the manufacturer at the global level for the period 2016-2021.
By Type and Application Segments
The report includes a detailed analysis of leading and type and application segments of the global Immunology Drug market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue sales analysis and forecast of the global Immunology Drug market by each type segment for the period 2016-2027. It also offers volume sales (consumption) analysis and forecast of the global Immunology Drug market by each type segment for the same period. Also, it provides volume sales (consumption) analysis and forecast of the global Immunology Drug market by each application segment for the same period.
This report includes the following manufacturers:
Abbott Laboratories
Active Biotech
Eli Lilly and Company
Autoimmune Inc.
Pfizer
GlaxoSmithKline plc
Seattle Genetics
Genentech
F. Hoffmann-La Roche Ltd.
Eisai Co.
Bayer AG
Sanofi Aventis LLC.
Market Segment by Type
Monoclonal Antibodies (mAb)
Antibody Drug Conjugates
Interferon and Cytokine therapies
Immunosuppressive medication
Market Segment by Application
Hospitals
Clinics
Cancer Research Centers and Institutes
Research Methodology
To compile the detailed study of the global Immunology Drug market, a robust research methodology has been adopted that aids in determining the key insights and also evaluates the growth prospects of the Immunology Drug market. LBI Research analysts have conducted in-depth primary and secondary research to obtain crucial insights into the Immunology Drug market. To carry out secondary research, the analysts have collected the information through company annual reports, journals, company press releases, and paid databases that were referred to gain and identify better opportunities in the global market.
1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Immunology Drug Market Size Growth Rate by Type
1.2.2 Monoclonal Antibodies (mAb)
1.2.3 Antibody Drug Conjugates
1.2.4 Interferon and Cytokine therapies
1.2.5 Immunosuppressive medication
1.3 Market Segment by Application
1.3.1 Global Immunology Drug Market Share by Application (2016 VS 2021 VS 2027)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Cancer Research Centers and Institutes
1.4 Study Objectives
1.5 Years Considered

2 Market Perspective
2.1 Global Immunology Drug Market Size (2016-2027)
2.1.1 Global Immunology Drug Revenue (2016-2027)
2.1.2 Global Immunology Drug Sales (2016-2027)
2.2 Global Immunology Drug Market Size across Key Geographies Worldwide: 2016 VS 2021 VS 2027
2.2.1 Global Immunology Drug Sales by Regions (2016-2021)
2.2.2 Global Immunology Drug Revenue by Regions (2016-2021)
2.3 Global Immunology Drug Market Size Forecast by Region
2.3.1 Global Immunology Drug Sales Forecast by Region (2022-2027)
2.3.2 Global Immunology Drug Revenue Forecast by Region (2022-2027)
2.4 Global Top Immunology Drug Regions (Countries) Ranking by Market Size
2.5 Immunology Drug Industry Trends
2.5.1 Immunology Drug Market Trends
2.5.2 Immunology Drug Market Drivers
2.5.3 Immunology Drug Market Challenges
2.5.4 Immunology Drug Market Restraints

3 Competitive Landscape by Manufacturers
3.1 Global Top Immunology Drug Manufacturers by Sales (2016-2021)
3.1.1 Global Immunology Drug Sales by Manufacturers (2016-2021)
3.1.2 Global Immunology Drug Sales Market Share by Manufacturers (2016-2021)
3.1.3 Global 5 and 10 Largest Manufacturers by Immunology Drug Sales in 2020
3.2 Global Top Manufacturers Immunology Drug by Revenue
3.2.1 Global Immunology Drug Revenue by Manufacturers (2016-2021)
3.2.2 Top Immunology Drug Manufacturers Covered: Ranking by Revenue
3.2.3 Global Immunology Drug Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Immunology Drug Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Immunology Drug as of 2020)
3.4 Global Immunology Drug Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Immunology Drug Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Immunology Drug Market
3.7 Key Manufacturers Immunology Drug Product Offered
3.8 Mergers & Acquisitions, Expansion Plans

4 Global Immunology Drug Market Size by Type
4.1 Global Immunology Drug Historic Market Review by Type (2016-2021)
4.1.1 Global Immunology Drug Sales Market Share by Type (2016-2021)
4.1.2 Global Immunology Drug Revenue Market Share by Type (2016-2021)
4.1.3 Immunology Drug Price by Type (2016-2021)
4.2 Global Immunology Drug Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Immunology Drug Sales Forecast by Type (2022-2027)
4.2.2 Global Immunology Drug Revenue Forecast by Type (2022-2027)
4.2.3 Immunology Drug Price Forecast by Type (2022-2027)

5 Global Immunology Drug Market Size by Application
5.1 Global Immunology Drug Historic Market Review by Application (2016-2021)
5.1.1 Global Immunology Drug Sales Market Share by Application (2016-2021)
5.1.2 Global Immunology Drug Revenue Market Share by Application (2016-2021)
5.1.3 Immunology Drug Price by Application (2016-2021)
5.2 Global Immunology Drug Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Immunology Drug Sales Forecast by Application (2022-2027)
5.2.2 Global Immunology Drug Revenue Forecast by Application (2022-2027)
5.2.3 Immunology Drug Price Forecast by Application (2022-2027)

6 North America
6.1 North America Immunology Drug Sales Breakdown by Company
6.1.1 North America Immunology Drug Sales by Company (2016-2027)
6.1.2 North America Immunology Drug Revenue by Company (2016-2027)
6.2 North America Immunology Drug Market Size by Type (2016-2027)
6.2.1 North America Immunology Drug Sales by Type (2016-2027)
6.2.2 North America Immunology Drug Revenue by Type (2016-2027)
6.3 North America Immunology Drug Market Size by Application (2016-2027)
6.3.1 North America Immunology Drug Sales by Application (2016-2027)
6.3.2 North America Immunology Drug Revenue by Application (2016-2027)
6.4 North America Immunology Drug Market Size by Country
6.4.1 North America Immunology Drug Sales by Country (2016-2027)
6.4.2 North America Immunology Drug Revenue by Country (2016-2027)
6.4.3 U.S.
6.4.4 Canada

7 Europe
7.1 Europe Immunology Drug Sales Breakdown by Company
7.1.1 Europe Immunology Drug Sales by Company (2016-2027)
7.1.2 Europe Immunology Drug Revenue by Company (2016-2027)
7.2 Europe Immunology Drug Market Size by Type (2016-2027)
7.2.1 Europe Immunology Drug Sales by Type (2016-2027)
7.2.2 Europe Immunology Drug Revenue by Type (2016-2027)
7.3 Europe Immunology Drug Market Size by Application (2016-2027)
7.3.1 Europe Immunology Drug Sales by Application (2016-2027)
7.3.2 Europe Immunology Drug Revenue by Application (2016-2027)
7.4 Europe Immunology Drug Market Size by Country
7.4.1 Europe Immunology Drug Sales by Country (2016-2027)
7.4.2 Europe Immunology Drug Revenue by Country (2016-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Immunology Drug Sales Breakdown by Company
8.1.1 Asia Pacific Immunology Drug Sales by Company (2016-2027)
8.1.2 Asia Pacific Immunology Drug Revenue by Company (2016-2027)
8.2 Asia Pacific Immunology Drug Market Size by Type (2016-2027)
8.2.1 Asia Pacific Immunology Drug Sales by Type (2016-2027)
8.2.2 Asia Pacific Immunology Drug Revenue by Type (2016-2027)
8.3 Asia Pacific Immunology Drug Market Size by Application (2016-2027)
8.3.1 Asia Pacific Immunology Drug Sales by Application (2016-2027)
8.3.2 Asia Pacific Immunology Drug Revenue by Application (2016-2027)
8.4 Asia Pacific Immunology Drug Market Size by Regions
8.4.1 Asia Pacific Immunology Drug Sales by Regions
8.4.2 Asia Pacific Immunology Drug Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam

9 Latin America
9.1 Latin America Immunology Drug Sales Breakdown by Company
9.1.1 Latin America Immunology Drug Sales by Company (2016-2027)
9.1.2 Latin America Immunology Drug Revenue by Company (2016-2027)
9.2 Latin America Immunology Drug Market Size by Type (2016-2027)
9.2.1 Latin America Immunology Drug Sales by Type (2016-2027)
9.2.2 Latin America Immunology Drug Revenue by Type (2016-2027)
9.3 Latin America Immunology Drug Market Size by Application (2016-2027)
9.3.1 Latin America Immunology Drug Sales by Application (2016-2027)
9.3.2 Latin America Immunology Drug Revenue by Application (2016-2027)
9.4 Latin America Immunology Drug Market Size by Country
9.4.1 Latin America Immunology Drug Sales by Country (2016-2027)
9.4.2 Latin America Immunology Drug Revenue by Country (2016-2027)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Immunology Drug Sales Breakdown by Company
10.1.1 Middle East and Africa Immunology Drug Sales by Company (2016-2027)
10.1.2 Middle East and Africa Immunology Drug Revenue by Company (2016-2027)
10.2 Middle East and Africa Immunology Drug Market Size by Type (2016-2027)
10.2.1 Middle East and Africa Immunology Drug Sales by Type (2016-2027)
10.2.2 Middle East and Africa Immunology Drug Revenue by Type (2016-2027)
10.3 Middle East and Africa Immunology Drug Market Size by Application (2016-2027)
10.3.1 Middle East and Africa Immunology Drug Sales by Application (2016-2027)
10.3.2 Middle East and Africa Immunology Drug Revenue by Application (2016-2027)
10.4 Middle East and Africa Immunology Drug Market Size by Country
10.4.1 Middle East and Africa Immunology Drug Sales by Country (2016-2027)
10.4.2 Middle East and Africa Immunology Drug Revenue by Country (2016-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 U.A.E

11 Company Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Corporation Information
11.1.2 Abbott Laboratories Overview
11.1.3 Abbott Laboratories Immunology Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.1.4 Abbott Laboratories Immunology Drug Products and Services
11.1.5 Abbott Laboratories Immunology Drug SWOT Analysis
11.1.6 Abbott Laboratories Recent Developments
11.2 Active Biotech
11.2.1 Active Biotech Corporation Information
11.2.2 Active Biotech Overview
11.2.3 Active Biotech Immunology Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.2.4 Active Biotech Immunology Drug Products and Services
11.2.5 Active Biotech Immunology Drug SWOT Analysis
11.2.6 Active Biotech Recent Developments
11.3 Eli Lilly and Company
11.3.1 Eli Lilly and Company Corporation Information
11.3.2 Eli Lilly and Company Overview
11.3.3 Eli Lilly and Company Immunology Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.3.4 Eli Lilly and Company Immunology Drug Products and Services
11.3.5 Eli Lilly and Company Immunology Drug SWOT Analysis
11.3.6 Eli Lilly and Company Recent Developments
11.4 Autoimmune Inc.
11.4.1 Autoimmune Inc. Corporation Information
11.4.2 Autoimmune Inc. Overview
11.4.3 Autoimmune Inc. Immunology Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.4.4 Autoimmune Inc. Immunology Drug Products and Services
11.4.5 Autoimmune Inc. Immunology Drug SWOT Analysis
11.4.6 Autoimmune Inc. Recent Developments
11.5 Pfizer
11.5.1 Pfizer Corporation Information
11.5.2 Pfizer Overview
11.5.3 Pfizer Immunology Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.5.4 Pfizer Immunology Drug Products and Services
11.5.5 Pfizer Immunology Drug SWOT Analysis
11.5.6 Pfizer Recent Developments
11.6 GlaxoSmithKline plc
11.6.1 GlaxoSmithKline plc Corporation Information
11.6.2 GlaxoSmithKline plc Overview
11.6.3 GlaxoSmithKline plc Immunology Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.6.4 GlaxoSmithKline plc Immunology Drug Products and Services
11.6.5 GlaxoSmithKline plc Immunology Drug SWOT Analysis
11.6.6 GlaxoSmithKline plc Recent Developments
11.7 Seattle Genetics
11.7.1 Seattle Genetics Corporation Information
11.7.2 Seattle Genetics Overview
11.7.3 Seattle Genetics Immunology Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.7.4 Seattle Genetics Immunology Drug Products and Services
11.7.5 Seattle Genetics Immunology Drug SWOT Analysis
11.7.6 Seattle Genetics Recent Developments
11.8 Genentech
11.8.1 Genentech Corporation Information
11.8.2 Genentech Overview
11.8.3 Genentech Immunology Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.8.4 Genentech Immunology Drug Products and Services
11.8.5 Genentech Immunology Drug SWOT Analysis
11.8.6 Genentech Recent Developments
11.9 F. Hoffmann-La Roche Ltd.
11.9.1 F. Hoffmann-La Roche Ltd. Corporation Information
11.9.2 F. Hoffmann-La Roche Ltd. Overview
11.9.3 F. Hoffmann-La Roche Ltd. Immunology Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.9.4 F. Hoffmann-La Roche Ltd. Immunology Drug Products and Services
11.9.5 F. Hoffmann-La Roche Ltd. Immunology Drug SWOT Analysis
11.9.6 F. Hoffmann-La Roche Ltd. Recent Developments
11.10 Eisai Co.
11.10.1 Eisai Co. Corporation Information
11.10.2 Eisai Co. Overview
11.10.3 Eisai Co. Immunology Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.10.4 Eisai Co. Immunology Drug Products and Services
11.10.5 Eisai Co. Immunology Drug SWOT Analysis
11.10.6 Eisai Co. Recent Developments
11.11 Bayer AG
11.11.1 Bayer AG Corporation Information
11.11.2 Bayer AG Overview
11.11.3 Bayer AG Immunology Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.11.4 Bayer AG Immunology Drug Products and Services
11.11.5 Bayer AG Recent Developments
11.12 Sanofi Aventis LLC.
11.12.1 Sanofi Aventis LLC. Corporation Information
11.12.2 Sanofi Aventis LLC. Overview
11.12.3 Sanofi Aventis LLC. Immunology Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.12.4 Sanofi Aventis LLC. Immunology Drug Products and Services
11.12.5 Sanofi Aventis LLC. Recent Developments

12 Value Chain and Sales Channels Analysis
12.1 Immunology Drug Value Chain Analysis
12.2 Immunology Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Immunology Drug Production Mode & Process
12.4 Immunology Drug Sales and Marketing
12.4.1 Immunology Drug Sales Channels
12.4.2 Immunology Drug Distributors
12.5 Immunology Drug Customers
13 Research Findings and Conclusion

14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
  • FORMAT: PDF
  • PUBLISHED DATE: Mar, 2021
  • NO OF PAGES: 101